BIOSCEPTRE INTERNATIONAL LIMITED

Company number 08729489 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Overview

Company type
Private Limited Company
Incorporated
2013-10-11
Registered office
Salisbury House, Station Road, Cambridge, United Kingdom, CB1 2LA
Postcode
CB1 2LA
Capital
90 GBP
Accounts category
Group

Accounts

Last made up to
2025-06-30
Next due by
2027-03-31
Financial year end
30 June

Confirmation statement

Last statement dated
2025-10-11
Next due by
2026-10-25
View filing history →

Nature of business (SIC)

  • 72110 Research and experimental development on biotechnology

Officers 7 current · 9 resigned

Colin WOOD Director
Appointed 2023-05-15
COMPANY DIRECTOR Appointed 2016-04-27
MR JON COLLINS Director
COMPANY DIRECTOR Appointed 2014-12-10
Appointed 2014-10-15
Appointed 2014-02-21

View all officers and resignations →

Group structure 1 subsidiary

From persons-with-significant-control filings on the public register.

Data protection registration

Registered with the ICO as a data protection fee payer — ZA280134 (Tier 1), registered since 2017.

Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.

Contact details

Website
biosceptre.com

A Promise Beyond Cancer Envisioning the future of targeted therapeutics Biosceptre is driving innovation to bring new and progressive therapies to a wide range of cancer patients. Our focus is a multiple-targeted universal CAR T system with the potential to improve the lives of millions of patients across the world who are suffering from

Among its peers

Among the oldest 25%

of 364 similar companies in CB, trading since 2013

376 companies are registered at this postcode →

The class of 2013

32%

of the 312 companies in this sector incorporated in 2013 are still active today; 63% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →